Why Humana’s Medicare Advantage Stumble Should Matter to Your Practice

Primary Care Perspective - Texas Edition | Tuesday, February 24, 2026

Strategic intelligence for independent primary care physicians in Texas.

Why This Landed on My Radar

Humana just disappointed Wall Street with its profit outlook, and my first thought wasn’t about their stock price - it was about what this signals for our Medicare Advantage contracts. When the second-largest MA player in the country starts struggling with margins, it doesn’t just affect their shareholders. It affects how aggressively they’ll negotiate our rates, how they’ll manage prior auths, and whether they’ll tighten networks. We need to understand what’s happening here.

Here’s What’s Going On

Humana reported adding more Medicare Advantage members than investors expected, but here’s the twist - that’s actually part of their problem. They grew enrollment, but their profit outlook still fell short, which tells you everything about the economics they’re facing right now. The company is dealing with the same headwinds hitting the entire MA sector: higher-than-expected medical costs, increased utilization post-pandemic, and CMS payment rates that aren’t keeping pace with actual care costs.

This isn’t just a Humana problem. The entire MA industry is facing margin compression. UnitedHealthcare, CVS/Aetna, and the other major players are all navigating the same storm. But Humana’s particular vulnerability - they’re more concentrated in MA than most other insurers - makes them the canary in the coal mine. When they sneeze, independent practices treating their Medicare patients should reach for a tissue.

The analyst commentary is telling: investors expected membership growth, just not this much at these margins. Translation: Humana is taking on members they might be losing money on, which means they’ll be looking everywhere to tighten costs.

What This Means for Your Practice

Here in Texas, where Medicare Advantage penetration keeps climbing and we’re already managing razor-thin margins, this matters more than you might think. BCBS Texas and United dominate our commercial market, but Humana has significant MA market share, especially in our metro areas - Houston, Dallas, San Antonio, Austin. When a major MA payer faces margin pressure, three things typically happen to practices like ours.

First, prior authorization gets more aggressive. We’re already spending hours every week fighting for approvals on what should be routine care. When payers face profit pressure, the prior auth machine shifts from annoying to suffocating. Expect longer delays, more denials on first submission, and peer-to-peers that feel more like adversarial proceedings than clinical discussions.

Second, contract negotiations get harder. If you’re up for renewal with Humana or any MA plan in the next 18 months, understand that their negotiating position just got more aggressive. They’re not coming to the table looking to improve our rates - they’re looking to hold the line or cut where they can. For independent practices without the leverage of a large health system, that’s a problem. We don’t have the volume to walk away from a major payer.

Third, and this is the one that keeps me up at night: network adequacy pressure might actually work in our favor short-term but hurt us long-term. MA plans need enough providers to meet CMS network adequacy requirements. In rural Texas, where we already have critical access challenges, plans can’t afford to cut too many physicians. But the flip side is they’ll keep us in-network at lower rates, knowing we don’t have better options. It’s the worst kind of job security.

The Texas-specific angle here is that we’re already operating with unique constraints. We have the largest uninsured population in the nation, no Medicaid expansion, and a patient mix that skews toward higher-acuity, higher-cost care. Our MA patients are often our best-reimbursed patients. If those reimbursement rates stagnate or shrink while our costs keep climbing, the math stops working.

This is exactly where better technology and systems could help us adapt - not by magically increasing reimbursement, but by helping us capture every dollar we’ve actually earned and reduce the administrative waste that’s killing our margins. When payers squeeze, practices that have tight coding, efficient workflows, and data to prove their value are the ones that survive negotiations with leverage.

Key Takeaways

• Humana’s margin pressure signals tighter prior authorization policies and tougher contract negotiations across all MA payers in the coming months
• Texas practices with high MA patient panels should audit their current authorization processes now - delays will get worse before they get better
• If you have MA contract renewals in 2026, start preparing your data and benchmarks early; showing quality metrics and cost-effectiveness will be critical leverage
• Consider diversifying your payer mix where possible, though in Texas with limited Medicaid and high uninsured rates, options are constrained
• Practices with clean coding, efficient revenue cycle operations, and strong utilization data will weather payer margin pressure better than those flying blind

What Smart Practices Are Doing

The practices I’m talking to are treating this as a wake-up call to get their house in order before contract renewal season. They’re running coding audits to ensure they’re capturing appropriate HCC codes for risk adjustment, documenting chronic conditions completely, and building data packets that demonstrate their value to MA plans. They’re also looking hard at their prior auth workflows to identify where automation or better systems could reduce the staff hours spent chasing approvals.

Source

“Humana’s profit outlook adds to health insurance gloom,” Modern Healthcare

Primary Care Perspective delivers curated intelligence from trusted healthcare sources.

© 2026 Primary Care Perspective | Texas Edition